BioLizard has supported the development of novel biomarker programs, contributed to AI-driven drug discovery efforts, and ...

Mairs & Power, an investment advisor, released the third-quarter 2025 investor letter for the “Mairs & Power Balanced Fund.” ...

Bio-Techne (TECH) announced a strategic collaboration between one of its spatial biology brands, Lunaphore, and the Wyss Center for Bio and Neuroengineering - Wyss Geneva ...

Bio-Techne Corporation (TECH) 53rd Annual Nasdaq Investor Conference December 9, 2025 4:30 AM ESTCompany ParticipantsKim Kelderman - CEO, President ...

A mega-sized fund aimed at supporting investments in key sectors, such as artificial intelligence (AI) and other advanced ...

Combines chemiluminescence detection with dual-channel fluorescence in the near-infrared and infrared (NIR and IR) ranges for expanded multiplexing Enables up to 24 targets per sample and supports ...

Vijayawada: In yet another step forward in creating a quantum ecosystem in Amaravati Quantum Valley (AQV), a delegation of researchers and technology .

RNA interference drug developer SanegeneBio leads our round-up of this week's biotech financings, with a $110 million Series ...

HANGZHOU, China and SHANGHAI and BOSTON, Dec. 10, 2025 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred ...

Reserves from Alabama football's 1925 national championship team featured impact-makers and future stars. Meet backups like ...

Biomanufacturing is a growing $500 billion industry that uses living systems such as algae to produce things such as ...

New ontologies for process data will help biopharmaceutical manufacturers enhance the interoperability of drug production operations ...